Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.
about
Notch3 signaling promotes the development of pulmonary arterial hypertensionTRPC6 in glomerular health and disease: what we know and what we believeRegulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Calcium regulates podocyte actin dynamics.Calcium-Sensing Receptor Regulates Cytosolic [Ca 2+ ] and Plays a Major Role in the Development of Pulmonary HypertensionNFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulationExpression levels of TRPC1 and TRPC6 ion channels are reciprocally altered in aging rat aorta: implications for age-related vasospastic disordersSildenafil inhibits chronically hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary arterial smooth muscleThe nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targetedBone morphogenetic protein 4 enhances canonical transient receptor potential expression, store-operated Ca2+ entry, and basal [Ca2+]i in rat distal pulmonary arterial smooth muscle cellsSerine-threonine kinase with-no-lysine 4 (WNK4) controls blood pressure via transient receptor potential canonical 3 (TRPC3) in the vasculatureHypertrophic scar contracture is mediated by the TRPC3 mechanical force transducer via NFkB activation.Transient receptor potential (TRP) channels: a clinical perspectiveSex differences in the pulmonary circulation: implications for pulmonary hypertensionAcute oxygen-sensing mechanisms.Attenuation of canonical transient receptor potential-like channel 6 expression specifically reduces the diacylglycerol-mediated increase in intracellular calcium in human myometrial cellsUpregulation of Na+ and Ca2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats.Emerging Metabolic Therapies in Pulmonary Arterial Hypertension.Down-regulation of TRPM8 in pulmonary arteries of pulmonary hypertensive rats.Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.The Role of TRPC6 in the Neuroprotection of Calycosin Against Cerebral Ischemic Injury.Upregulation of Oct-4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertensionGenomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.The Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary VasculatureGene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesClassical transient receptor potential 1 and 6 contribute to hypoxic pulmonary hypertension through differential regulation of pulmonary vascular functions.Increased vascular smooth muscle contractility in TRPC6-/- mice.Regulation of pulmonary vasoconstriction by agonists and caveolae.Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodelingCellular functions of transient receptor potential channels.Flow shear stress enhances intracellular Ca2+ signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.Upregulation of Na+/Ca2+ exchanger and TRPC6 contributes to abnormal Ca2+ homeostasis in arterial smooth muscle cells from Milan hypertensive rats.Inhibition of TRPC6 degradation suppresses ischemic brain damage in rats.Expression of TRPC6 in renal cortex and hippocampus of mouse during postnatal development.High altitude pulmonary hypertension: role of K+ and Ca2+ channels.Treating pulmonary arterial hypertension: current treatments and future prospectsRat strain differences in pulmonary artery smooth muscle Ca(2+) entry following chronic hypoxia.
P2860
Q24310736-AC497948-28C1-4449-89E4-B824E4A533C7Q24652809-351ADA50-7CA9-4B14-808A-BF428066E2F5Q27330365-58CB0C14-8DAF-41B5-8938-A9931CB1FD04Q27687091-073119BA-6092-4789-B521-F177DA3DCA31Q27692627-CA697C03-80BD-445B-ABDD-CDECD68EC93FQ28069319-1ACF375A-420C-4ACC-90FC-B1C292F5DE8EQ28509338-13E3E14E-7A68-41B6-A16A-BE8170AC33C0Q28564249-52079F50-4B1C-49FD-A5DA-C864D37E596DQ28567504-7D82D7F0-1A2D-4817-89A9-ED531C6FE29AQ28567772-55B257EC-42C9-4C26-AFED-664C7AE5F67FQ28569097-68EF047B-B3EB-4151-8919-BB85033D6A47Q30501923-815D34E0-A5C4-4262-9323-2DA0A3930DEEQ30655602-1246EF3A-A67C-4E60-A8C9-1E4651C288A5Q33562143-C28B27BE-1422-4E82-981B-669627392506Q33568826-60C390CF-6180-402A-B6EA-D8FF582DF55FQ33577287-572462DB-7E68-428A-9B87-57B54549FEABQ33577535-32DAFAD4-EE96-4825-AB09-32D0D8030C02Q33589231-B9A6C5D9-FAED-4B4F-9EAC-EDBCDD065D1CQ33608219-465773C2-57BB-4C26-85EE-FDB4615FD292Q33668314-2477B364-04C0-4300-9417-2F0ABD0C12ADQ33705025-1CB2A36F-4446-4028-9488-9C2E2A0E5AC3Q33764566-CC1BD630-0C89-471D-A96D-99D341AD443EQ33780456-F86A9BBC-031D-4E53-9906-403B09A2A1FFQ33784103-A4E47E95-CB50-4E91-A38D-F31DE23352F2Q33784417-8ADE0D3A-CC63-4376-B989-9D67CCA8B6BAQ33804336-0697DC13-CB62-43E5-8F4E-4D5FD71D086EQ33831900-95C042CC-8D58-418A-B49F-69105E17B9ECQ33849207-21189188-5AA3-43A6-8D3F-575921E57C36Q33915272-F226F2A0-E80C-4321-BAB2-1C07E4AC2A18Q33924920-0D45D5AA-9CE5-486A-A55D-71B9D497FD80Q33925116-3A4DE305-0F3B-4954-986E-9B4D1C3586E7Q33925149-C0D8203E-FE1E-4BAE-8449-E118D6CEFC05Q34020976-B8C8450E-6DE7-4D5F-8E8B-E427044C32DDQ34062874-494DFDDC-1281-4BA1-97BD-2458A8336635Q34150529-D1263F42-E638-4C7A-8BE9-4A89DB63885DQ34162188-96AF1699-02B9-4105-A737-163962370710Q34305480-78F73BDC-1D61-404E-9D9F-061C747D2C26Q34314214-68456D25-455F-436A-8A6C-0F249D85D555Q34318473-6C372CF4-C6B8-4A01-8E92-56BF0CD89C08Q34383236-686F48E4-E182-49EF-B58E-2C4631576408
P2860
Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhanced expression of transie ...... lmonary arterial hypertension.
@en
Enhanced expression of transie ...... lmonary arterial hypertension.
@nl
type
label
Enhanced expression of transie ...... lmonary arterial hypertension.
@en
Enhanced expression of transie ...... lmonary arterial hypertension.
@nl
prefLabel
Enhanced expression of transie ...... lmonary arterial hypertension.
@en
Enhanced expression of transie ...... lmonary arterial hypertension.
@nl
P2093
P2860
P356
P1476
Enhanced expression of transie ...... lmonary arterial hypertension.
@en
P2093
Carmelle V Remillard
Donna D Tigno
Ivana Fantozzi
Jason X-J Yuan
Judd W Landsberg
Lewis J Rubin
Naomi Kunichika
Oleksandr Platoshyn
Patricia A Thistlethwaite
P2860
P304
13861-13866
P356
10.1073/PNAS.0405908101
P407
P577
2004-09-09T00:00:00Z